Prohibition Partners
Home / Cannabis Markets / Austria
Austria flag

Is cannabis legal in Austria?

Medical cannabis is legal in Austria and adult-use is illegal. Below: a free market overview, with the full sizing, regulation and trade data available from PP.

Medical: LegalAdult-use: IllegalMarket activates in 2027 (projected)

Market size

Medical cannabis sales and registered patients in Austria, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the Austria data pack.

Medical sales, EUR

20252026€134.3k2027202820292030
Metric202520262027202820292030
Medical sales€134.3k
Patients220

Forecasts to 2030 — sales, patients and the full Austria series — are in the Austria data pack, or scoped to your question in a bespoke brief.

See the data pack Request a brief

Source: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)

Recently in Austria

From International Cannabis Weekly, our free global briefing.

Latest issue №467
  1. Austria's THC referendum initiative enters crucial procedural phase

    Hanf Magazin · 466 · 11 Sept 2026 · Regulation

  2. Vienna multiple sclerosis patient launches legal fight to grow medical cannabis at home

    Hanf Magazin · 459 · 17 Jul 2026 · Medical

  3. Austrian court has ruled on tobacco use with hemp flowers in brand new legal case

    Newsweed · 448 · 8 May 2026 · Regulation

  4. Austria considers tobacco-shop monopoly for CBD flowers

    Newsweed · 428 · 28 Nov 2025 · Regulation

  5. A new transitional solution for CBD flowers in Austria has been extended until 2028

    Hanf Magazin · 427 · 21 Nov 2025 · Hemp & CBD

  6. Austria-based Sanlight introduces grow lighting technology to US market

    bevinfogroup.com · 416 · 5 Sept 2025 · Business & Investment

Medical cannabis — overview

The Austrian Narcotics Act (SMG) allows for the production, acquisition, processing, transport, possession, import, or export of narcotic substances for medical or scientific purposes. The SMG refers specifically to medical cannabis, and states that the Austrian Agency for Health and Food Safety (AGES), is the only entity in Austria permitted to cultivate and possess cannabis for the production of medicinal products.

AGES grows several hundred kilograms of cannabis flower each year, which it exports to Germany, where it is processed into dronabinol, some or all of which is re-imported.

Semi-synthetic dronabinol preparations have been available to patients in Austria since 2004 as a magistral treatment in the form of oils or capsules, with 95% pure cannabis-extracted dronabinol available since 2015. Dronabinol prescriptions must be written by a senior physician, with a strict approval process in place.

Dronabinol treatment in Austria is most likely to be used for patients with spasticity, paralysis, multiple sclerosis and other nervous disorders, for the relief of chronic pain that does not respond to any other therapy (cancer, diseases of the nervous system), or loss of appetite, nausea and vomiting in cancer and AIDS.